MDI-2268

N/A

Report date: 2025/01/26 16:31:23
NME

Base Information

Drug NameMDI-2268
Drug Alias Nameplasminogen activator inhibitor type-1 (University of Michigan)PAI-1 inhibitor (University of Michigan)MDI-2268
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsScleroderma-associated interstitial lung diseasesFibrosisVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesMDI Therapeutics Inc
Inactive CompaniesUniversity Of Michigan
Active IndicationsFibrosis
Inactive IndicationsScleroderma-associated interstitial lung diseasesVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A